期刊文献+

亚临床甲状腺功能减退加重冠心病危险性的相关研究 被引量:3

原文传递
导出
摘要 目的对亚临床甲状腺功能减退与冠心病的发生及发展的危险性的相关研究进行综述。方法查阅相关研究文献,分析并总结亚临床甲状腺功能减退加重冠心病危险性的相关性。结果亚临床甲状腺功能减退可以从多方面加速动脉粥样硬化的形成与发展,并可损害心脏的收缩、舒张功能,进而促进心血管事件的发生与发展,但此病理性改变过程是可逆性的。结论亚临床甲状腺功能减退在冠心病的发生与发展过程中起着重要的作用,但亚临床甲减是否是心血管事件的危险因素还有待进一步相关的临床研究来证明,以便更好地指导临床对其的预防、治疗与筛查。
作者 李颖
机构地区 天津市第二医院
出处 《首都医药》 2013年第6期22-23,共2页 Capital Medicine
  • 相关文献

参考文献13

  • 1周仁,刘泽林.左旋甲状腺素治疗对亚临床甲状腺功能减退患者血脂和症状影响[J].中华内分泌代谢杂志,2003,19(6):461-462. 被引量:6
  • 2Karmisholt J, hndersen S, Laurberg P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism[J] Thyroid, 2008, 18 (3): 303- 308.
  • 3Yilmaz HY, Ertu Rul Z, Ertu Rul BI, et al. Mean plateletvolume in patients with subclinical hypothyroidism[J]. Flatelets, 2011,22(2):143- 147.
  • 4Erikci hA, Karagoz B, Ozturk h, et a/.The effect of sub--clinical hypothyroidism on platelet parameters [J]. Hema t o 1 o gy, 2009, 1,1(2): 115 - 117.
  • 5Duan Y, Peng W Community--based Wang X, et al. study of the association of subclinical thyroid dysfunction withblood pressure[J] Endocrine, 2009, 35 (2): 136- 142.
  • 6hdrees M, Gibney J, gl-Saeity N, et sl. Effects of 18 months of L--T4 replacement in women with subclinical hypothyroidism[J].Clin gndocrinoi(Oxf),2009,71(2):298-303.
  • 7Walsh JP, Bremner AP, Bu lsaru Mk. Sub clinical thyroidys function and blood ressure: a Commmurity hase duty [J]. C1 in Endocr ionol (oxf), 2006, 65 (4) : 486.
  • 8Toruner F, hltinova hE, Karakoc h, et al. Risk factorsfor cardiovascular disease in patients with subclinical hypothyroidism[J].hdv Ther, 2008, 25 (5) : 430 - 437.
  • 9hsvold Bo, Bjoro aI. Association T, Nilsen TL, et between blood pressure and serum thryoid- stimulating hormone conce within the reference population-based study[ docrinol & Metab, 2007,92(5): ntration range: a J].Clin 841.
  • 10涂燕平,雷梦觉,吴小和,龚爱斌,魏伟荣,王凌玲,艾文伟,邬甦,姚晓璐.亚临床甲状腺功能减退对冠状动脉粥样硬化性心脏病患者C反应蛋白及尿微量白蛋白的影响[J].中国医药,2011,6(3):262-263. 被引量:16

二级参考文献32

  • 1Surks MI,Ortiz E,Daniels G H,et al.Subclinical thyroid disease:scientific review and guidelines for diagnosis and management.JAMA,2004,291(2):228-238.
  • 2Canaris GJ,Manowitz NH,Mayor GM,et al.The Colorado thyroid disease prevalence study.Arch Intern Med,2000,160(4):526-534.
  • 3Velkoska Nakova V,Krstevska B,Bosevski M,et al.Dyslipidaemia and hypertension in patients with subclinical hypothyroidism.Prilozi,2009,30 (2):93-102.
  • 4Turhan S,Sezer S,Erden G,et al.Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.Ann Saudi Med,2008,28(2):96-101.
  • 5Erdem TY,Ercan M,Ugurlu S,et al.Plasma viscosity,an early cardiovascular risk factor in women with subclinical hypothyroidism.Clin Hemorheol Microcirc,2008,38(4):219-225.
  • 6Taddei S,Caraccio N,Virdis A,et al.Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism:beneficial effect oflevothyroxine therapy.J Clin Endocrinol Metab,2003,88(8):3731-3737.
  • 7RodondiN,den Elzen WP,Bauer DC,et al.Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality.JAMA,2010,304(12):1365-1374.
  • 8Razvi S,Weaver JU,Vanderpump MP,et al.The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism:reanalysis of the Whickham Survey cohort.J Clin Endocrinol Metab,2010,95(4):1734-1740.
  • 9Razvi S,Ingoe L,Keeka G,et al.The beneficialeffect of L-thyroxine on cardiovascular risk factors,endothelial function,and quality of life in subclinical hypothyroidism:randomized,crossover trial.J Clin Endocrinol Metab,2007,92(5):1715-1723.
  • 10Gharib H.Review:available evidence does not support a benefit for thyroid hormone replacement in adults with subclinical hypothyroidism.Evid Based Med,2008,13(1):22.

共引文献53

同被引文献29

  • 1郑刚.亚临床甲状腺功能减退与冠心病相关性研究的现状[J].中华临床医师杂志(电子版),2011,5(12):3576-3580. 被引量:5
  • 2Yun KH,Jeong MH,Oh SK,et a1. Relationship of thyroid stimulating hormone with coronary atheroselerosis in angina patients[J].Int J Car-diol,2007,(01):56-6O.
  • 3Walsh JP,Bremner A P,Bulsara M K. Subclinical thyroid dys-function as a risk factor for cardiovascular disease[J].Archives of Internal Medicine,2005,(21):2464-2472.
  • 4Nakova VV,Krstevska B,Bosevski M,et a1. Dyslipidemia and hyper-tension in patients with subclinical hypothyroidism[J].Prilozi,2009,(02):93-102.
  • 5Blond B,Palmieri EA,Klain M,et a1. Subclinical hypothyroidism. Clinical feature and treatment opinion[J].Eurdocrinol,2005,(01):1-9.
  • 6CanarisGJ,ManowizNR,MayorG,etal.TheCoioradothyroiddiseaseprevalencestudy[J].ArchInternMed,2000,160(4):526-534.
  • 7NakovaVV,KrstevskaB,BosevskiM,etal.Dyslipidemiaandhypertensioninpatientswithsubclinicalhypothyroidism[J].Prilozi,2009,30(2):93-102.
  • 8TurhanS,SezerS,ErdenG,etal.Plasmahomocysteineconcentrationsandserumlipidprofileasatheroscleroticriskfactorsinsubclinicalhypothyroidism[J].AnnSoudiMed2008,28(2):96-101.
  • 9RodondiN,denElzenWP,BauerDC,etal.Subclinicalhypothyroidismandtheriskofcoronaryheartdiseaseandmortality[J].JAMA,2010,304(12):1356-1374.
  • 10张建勋,李海鹃,薛涛.等.分析亚临床甲状腺功能减退与冠心病的相关性[J].世界临床医学,2015.9(12):100.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部